ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
75 announcements
Anupam Rasayan announced a ₹300 Crore acquisition of a 43.3-48.2% stake in Bliss GVS Pharma Limited. The deal integrates its specialty chemical capabilities with pharmaceutical formulations.
Anupam Rasayan reported FY26 revenue of ₹2,383.60 Crore, a 65% YoY increase. Performance was driven by landmark sales, strategic expansion, and the Jayhawk acquisition.
Anupam Rasayan's board approved the re-appointment of its internal and cost auditors for FY 2026-27. The meeting concluded today, ensuring continuity in corporate governance and audit functions.
Mr. Vishal Thakkar resigned as Deputy CFO and Key Managerial Personnel effective May 23, 2026. He departs to explore internal Group opportunities and personal ventures.
Anupam Rasayan will acquire up to 74.20% of Bliss GVS Pharma for approximately ₹2250.36 Crore. This strategic acquisition strengthens the company's presence across the pharmaceutical value chain.
Anupam Rasayan India Ltd reported revenue from operations of ₹635.8 Cr (+27.1% YoY) and net profit of ₹56 Cr (-11.0% YoY) for Q4 FY26.
Anupam Rasayan reported audited FY2026 financial results and recommended a ₹1.5 dividend per share. The board also approved a 74.20% acquisition of Bliss GVS Pharma.
Anupam Rasayan India Limited has scheduled a board meeting for May 23, 2026. The board will consider audited yearly financial results, final dividend, and fund raising.
Anupam Rasayan India Ltd scheduled a board meeting for May 23, 2026. Directors will consider financial results, a final dividend, and ₹160 Crore NCD issuance.
Anupam Rasayan India Limited announced the successful passage of resolutions via postal ballot. Shareholders approved guarantees and security interests for credit facilities involving subsidiary Doriath S.a.r.l.
Anupam Rasayan India Limited shareholders approved two resolutions via postal ballot with majority. The voting results and scrutinizer's report were formally filed today.
Anupam Rasayan India Limited has issued a Postal Ballot notice to shareholders. The resolutions seek approval for providing guarantees and security interests regarding credit facilities for Doriath S.à.r.l. and Jayhawk Fine Chemicals Corporation. Voting concludes on May 7, 2026.
Anupam Rasayan India Ltd has issued a Postal Ballot notice seeking shareholder approval for guarantees and security interests related to a $20 million (₹186 Crore) credit facility. The facility, from Altis XII Pte. Ltd., funded the acquisition of Jayhawk Fine Chemicals. Approval ensures security continuity even if the borrowing subsidiary's ownership status changes.
Anupam Rasayan India Ltd reported net profit of ₹60.6 Cr (+11.8% YoY) for Q3 FY26.
Anupam Rasayan India Limited approved a Postal Ballot notice to seek shareholder consent for providing guarantees and security interests for credit facilities availed by its subsidiary, Doriath S.à.r.l. The board also fixed April 03, 2026, as the cut-off date for eligibility to vote via remote e-voting.